These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11905586)

  • 41. Apolipoprotein E phenotypes, serum lipoproteins and apolipoproteins in angiographically assessed coronary heart disease.
    Stuyt PM; Brenninkmeijer BJ; Demacker PN; Hendriks JC; van Elteren P; Stalenhoef AF; van 't Laar A
    Scand J Clin Lab Invest; 1991 Sep; 51(5):425-35. PubMed ID: 1947727
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiovascular prognosis in relation to apolipoproteins and other lipid parameters in patients with stable angina pectoris treated with verapamil or metoprolol: results from the Angina Prognosis Study in Stockholm (APSIS).
    Held C; Hjemdahl P; Rehnqvist N; Björkander I; Forslund L; Brodin U; Berglund L; Angelin B
    Atherosclerosis; 1997 Nov; 135(1):109-18. PubMed ID: 9395279
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Apolipoprotein (a) polymorphism in relation to coronary heart disease in Chinese Han nationality].
    Qin S; Wang S; Li C
    Zhonghua Yi Xue Za Zhi; 1995 Oct; 75(10):588-91, 637-8. PubMed ID: 8697071
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interactions of lipoprotein(a) with diabetes mellitus, apolipoprotein B and cholesterol enhance the prognostic values for coronary artery disease.
    Rasouli M; Kiasari AM
    Clin Chem Lab Med; 2008; 46(5):667-73. PubMed ID: 18598204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease.
    Kraft HG; Lingenhel A; Köchl S; Hoppichler F; Kronenberg F; Abe A; Mühlberger V; Schönitzer D; Utermann G
    Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):713-9. PubMed ID: 8640397
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion.
    Mendoza SG; Zerpa A; Carrasco H; Colmenares O; Rangel A; Gartside PS; Kashyap ML
    Artery; 1983; 12(1):1-23. PubMed ID: 6431945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lipoprotein (a) in subjects with or without coronary artery disease: relation to clinical history and risk factors.
    Maranhão RC; Vinagre CG; Arie S; Guimarães JB; da-Luz P; Bellotti G; Pileggi F
    Braz J Med Biol Res; 1995 Apr; 28(4):439-46. PubMed ID: 8520541
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
    Tsimikas S; Brilakis ES; Miller ER; McConnell JP; Lennon RJ; Kornman KS; Witztum JL; Berger PB
    N Engl J Med; 2005 Jul; 353(1):46-57. PubMed ID: 16000355
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dose-response relationships of serum lipid measurements with the extent of coronary stenosis. Strong, independent, and comprehensive. ECAT Angina Pectoris Study Group.
    Bolibar I; Thompson SG; von Eckardstein A; Sandkamp M; Assmann G
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1035-42. PubMed ID: 7627693
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Relationship between serum levels of osteoproteins, inflammatory cytokines and coronary heart disease and disease severity].
    Zhao F; Zhang R; Zhao H; Liu T; Ren M; Song Y; Liu S; Cong H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 May; 31(5):588-593. PubMed ID: 31198145
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Study of apo(a) length polymorphism and lipoprotein(a) concentrations in subjects with single or double apo(a) isoforms.
    Alaoui M; Merle C; Garnotel R; Jolly D; Durlach V; Gillery P
    Clin Chem Lab Med; 2003 May; 41(5):634-9. PubMed ID: 12812260
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
    Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
    Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is lipoprotein(a) a predictor for survival in patients with established coronary artery disease? Results from a prospective patient cohort study in northern Sweden.
    Glader CA; Birgander LS; Stenlund H; Dahlén GH
    J Intern Med; 2002 Jul; 252(1):27-35. PubMed ID: 12074735
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipoprotein(a) level and apolipoprotein(a) phenotype as predictors of long-term cardiovascular outcomes after coronary artery bypass grafting.
    Ezhov MV; Safarova MS; Afanasieva OI; Kukharchuk VV; Pokrovsky SN
    Atherosclerosis; 2014 Aug; 235(2):477-82. PubMed ID: 24952151
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the ARIC study.
    Ndumele CE; Matsushita K; Astor B; Virani SS; Mora S; Williams EK; Hoogeveen RC; Blumenthal RS; Sharrett AR; Ballantyne CM; Coresh J
    Eur J Prev Cardiol; 2014 Jul; 21(7):866-75. PubMed ID: 23109406
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic importance of plasma lipoprotein-analyses in patients with unstable coronary artery disease.
    Swahn E; Von Schenck H
    Scand J Clin Lab Invest; 1993 May; 53(3):289-95. PubMed ID: 8316757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women.
    Cubrilo-Turek M; Stavljenić-Rukavina A; Sertić J; Zrinski R; Turek S; Grgac G; Ljubojević N
    Coll Antropol; 1998 Jun; 22(1):149-55. PubMed ID: 10097431
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Plasma levels of lipids, lipoproteins and apolipoproteins affected by endogenous testosterone].
    Zhao S; Li X; Wang Z
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(3):299-301. PubMed ID: 10681765
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).
    Hartgens F; Rietjens G; Keizer HA; Kuipers H; Wolffenbuttel BH
    Br J Sports Med; 2004 Jun; 38(3):253-9. PubMed ID: 15155420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.